"It is important for us to protect our work and furthermore these patents are a proof of our unique technology", says Yvonne Mårtensson, CEO at CellaVision AB. "Our policy is to apply for patent of all the inventions we believe to be valuable assets in our commercial products and in discussions with significant players on the hematology market".
The latest four patented inventions have all been approved during 2002. These include;
· a CD-player-like circular scanning of a specimen
· spinning of the blood sample
· automatic focusing on the blood sample
· composing of high quality color images using an optical system with limited chromatic compensation.
"The recently patented method for automatic focusing on the blood sample during blood smear analysis is for example a very important component of our product DiffMasterÔ Octavia. This method enables for optimal focus on each individual cell during the collection. It is important to make the cell images of as high quality as possible", says Yvonne Mårtensson, CEO at CellaVision AB. With our cutting edge technology we have established CellaVision as a leading company in the advanced digital image analysis market for medical diagnostics and laboratory medicine".
For further information, please contact:
Johan Ericsson, Vice President of Engineering, CellaVision AB, +46 (0)46-286 44 44,
+46 (0) 708-20 58 11, johan.ericsson@cellavision.se